0001493152-26-009017
SEC filingOn February 27, 2026, Joseph DosSantos, SVP, Finance and Acting Chief Financial Officer of Celularity Inc., left the Company for personal reasons. The Company appointed John Sprague as Acting Chief Financial Officer on the same date.